Anemia probe focuses on dialysis treatment
DIALYSIS solution is suspected of being the cause of anemia in 23 patients in a state-owned hospital in east China's Jiangsu Province.
One patient died of complications at Lianyungang City No. 1 People's Hospital after his red blood cell levels dropped earlier this month.
The other 22 affected patients - out of 79 who were receiving dialysis at the hospital - are in a stable condition, said the local health bureau.
An investigation is under way to pinpoint the cause.
The solution is made by dissolving dialysis powder in processed tap water.
Tests have found the water safe, according to a monitoring center under the Ministry of Land and Resources, Xinhua news agency reported yesterday.
Attention has now turned to the powder itself. Samples have been sent to testing centers in the provincial capital Nanjing, Shanghai, Beijing and Tianjin for examination.
The remaining 600 bags in the batch have been sealed.
However, a lack of national standards makes it difficult for the hospital to determine whether ingredients are safe.
The hospital is seeking to conduct further tests, it was reported. Earlier investigations by the hospital and health authorities found no contamination in the treatment.
The Lianyungang hospital suspended dialysis treatment on December 22 and transferred dialysis patients to other hospitals.
A patient, surnamed Zhou, died after suffering a stroke following dialysis at the hospital, the hospital said. A postmortem is required to determine whether Zhou's death is linked to dialysis solution, local officials said.
One patient died of complications at Lianyungang City No. 1 People's Hospital after his red blood cell levels dropped earlier this month.
The other 22 affected patients - out of 79 who were receiving dialysis at the hospital - are in a stable condition, said the local health bureau.
An investigation is under way to pinpoint the cause.
The solution is made by dissolving dialysis powder in processed tap water.
Tests have found the water safe, according to a monitoring center under the Ministry of Land and Resources, Xinhua news agency reported yesterday.
Attention has now turned to the powder itself. Samples have been sent to testing centers in the provincial capital Nanjing, Shanghai, Beijing and Tianjin for examination.
The remaining 600 bags in the batch have been sealed.
However, a lack of national standards makes it difficult for the hospital to determine whether ingredients are safe.
The hospital is seeking to conduct further tests, it was reported. Earlier investigations by the hospital and health authorities found no contamination in the treatment.
The Lianyungang hospital suspended dialysis treatment on December 22 and transferred dialysis patients to other hospitals.
A patient, surnamed Zhou, died after suffering a stroke following dialysis at the hospital, the hospital said. A postmortem is required to determine whether Zhou's death is linked to dialysis solution, local officials said.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.